Versapay (VPY) PT Set at C$3.30 by Raymond James

Share on StockTwits

Versapay (CVE:VPY) has been given a C$3.30 price target by equities research analysts at Raymond James in a note issued to investors on Wednesday. The brokerage presently has an “outperform” rating on the stock. Raymond James’ target price indicates a potential upside of 134.04% from the company’s current price.

Separately, Eight Capital set a C$2.00 target price on Versapay and gave the company a “buy” rating in a report on Monday, December 3rd.

VPY stock opened at C$1.41 on Wednesday. Versapay has a fifty-two week low of C$0.91 and a fifty-two week high of C$2.74. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.41 and a current ratio of 1.23. The stock has a market capitalization of $59.67 million and a price-to-earnings ratio of -4.38.

Versapay Company Profile

VersaPay Corporation, a financial technology company, provides cloud-based invoicing, accounts receivable (A/R) management, and payment solutions for businesses in Canada and the United States. The company offers ARC, a business-to-business solution that delivers capabilities in areas, such as invoice presentment, collaboration and collection, electronic payment, cash application, and A/R insight; PayPort, a cloud-based credit card and electronic funds transfer service; and Gateway that allows third party technology partners to connect to PayPort through a secure application program interface and offer the service as part of their own service offering.

Featured Article: What is the float in trading stocks?

Receive News & Ratings for Versapay Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versapay and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

SDX Energy  Stock Price Down 8.2%
SDX Energy Stock Price Down 8.2%
Wishbone Gold  Trading Up 15.7%
Wishbone Gold Trading Up 15.7%
Bacanora Lithium  Earns Buy Rating from VSA Capital
Bacanora Lithium Earns Buy Rating from VSA Capital
Cello Health  Given Corporate Rating at FinnCap
Cello Health Given Corporate Rating at FinnCap
JPMorgan Chase & Co. Cuts Crest Nicholson  Price Target to GBX 400
JPMorgan Chase & Co. Cuts Crest Nicholson Price Target to GBX 400
adidas  Given a €220.00 Price Target at Baader Bank
adidas Given a €220.00 Price Target at Baader Bank


© 2006-2019 Ticker Report